Plain-English translation of NCT07305922 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study for people recovering from a subarachnoid hemorrhage—a type of brain bleed from a ruptured aneurysm. Researchers want to understand what happens when blood vessels in the brain narrow severely after this kind of hemorrhage, and how current treatments like medication and blood pressure management affect outcomes. The study uses advanced monitoring tools to track your brain's condition closely.
After a brain hemorrhage, blood vessels can narrow dangerously and cause a stroke—even after the initial bleeding is stopped. This study aims to better understand why this happens and how doctors can better prevent it using the treatments already available.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive intensive monitoring of your brain's blood vessels and function during your stay in the hospital's critical care unit. This involves specialized ultrasound tests and other non-invasive monitoring tools that your medical team will use regularly to watch for problems. The study tracks how well current treatments work to prevent blood vessel narrowing and stroke.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Sweden
Region Stockholm
Collaborators
Karolinska Institutet
Enrollment target
~200 participants
Started
December 2025
Primary completion
December 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Peter C Rudberg, M.D. Ph.D.
Region Stockholm
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.